StonvexLoading…
StonvexStonvexStonvexCore line items from EGAN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $68.99M | $46.49M | $23.51M | $88.43M |
Operating Income | $6.89M | $4.88M | $2.83M | $4.43M |
Net Income | $7.57M | $5.16M | $2.82M | $32.25M |
EPS (Diluted) | $0.27 | $0.19 | $0.10 | $1.13 |
Total Assets | $139.69M | $146.77M | $144.61M | $148.00M |
Total Liabilities | $48.13M | $57.98M | $61.08M | $67.27M |
Cash & Equivalents | $80.46M | $83.06M | $70.90M | $62.91M |
Free Cash Flow OCF − CapEx | $18.21M | $20.08M | $10.21M | $4.70M |
Shares Outstanding | 27.45M | 27.38M | 26.91M | 27.08M |